{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:18:53Z","timestamp":1759421933224,"version":"3.37.3"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210076","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T18:32:43Z","timestamp":1547663563000},"page":"e0210076","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Human leukocyte antigen and demographic characteristics in Chinese patients with active peripheral type psoriatic arthritis who had inadequate response to conventional disease-modifying antirheumatic drugs in a single dermatologic clinic"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-6964","authenticated-orcid":true,"given":"Chi-Zai","family":"Sin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Shun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1474","authenticated-orcid":true,"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"issue":"7","key":"ref1","first-page":"1354","article-title":"Incidence and prevalence of psoriatic arthritis: a systematic review","volume":"35","author":"Y Alamanos","year":"2008","journal-title":"The Journal of rheumatology"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3899\/jrheum.141598","article-title":"Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan","volume":"42","author":"Y Ohara","year":"2015","journal-title":"The Journal of rheumatology"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-015-3365-3","article-title":"Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires","volume":"36","author":"D Shin","year":"2016","journal-title":"Rheumatology international"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2340\/00015555-0253","article-title":"Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population","volume":"87","author":"X Fan","year":"2007","journal-title":"Acta dermato-venereologica"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0378-6323.32739","article-title":"A clinical study of psoriatic arthropathy","volume":"73","author":"PV Prasad","year":"2007","journal-title":"Indian journal of dermatology, venereology and leprology"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1523-1747.2000.00863.x","article-title":"The association of psoriasis with human leukocyte antigens in Korean population and the influence of age of onset and sex","volume":"114","author":"TG Kim","year":"2000","journal-title":"The Journal of investigative dermatology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00403-002-0324-0","article-title":"HLA-Cw6 specificity and polymorphic residues are associated with susceptibility among Chinese psoriatics in Taiwan","volume":"294","author":"T-F Tsai","year":"2002","journal-title":"Archives of dermatological research"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00376613","article-title":"Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis","volume":"283","author":"H Nakagawa","year":"1991","journal-title":"Archives of dermatological research"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2340\/0001555577273276","article-title":"Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP)","volume":"77","author":"C Enerback","year":"1997","journal-title":"Acta Dermato Venereologica"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0198-8859(98)00123-2","article-title":"HLA-C locus alleles in patients with psoriatic arthritis (PsA)","volume":"60","author":"DD Gladman","year":"1999","journal-title":"Human immunology"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2097","article-title":"HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis","volume":"8","author":"R Queiro","year":"2006","journal-title":"Arthritis research & therapy"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/ard.2006.064972","article-title":"HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis","volume":"66","author":"PY Ho","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jdermsci.2016.08.535","article-title":"Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan","volume":"84","author":"TS Wang","year":"2016","journal-title":"Journal of dermatological science"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2133.2011.10688.x","article-title":"HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis","volume":"166","author":"H Chiu","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"ref15","first-page":"412","article-title":"A review of clinical trials of biologic agents and small molecules for psoriasis in Asian subjects","volume":"151","author":"YC Tsai","year":"2016","journal-title":"Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"e20279","DOI":"10.1371\/journal.pone.0020279","article-title":"Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis","volume":"6","author":"KM Wittkowski","year":"2011","journal-title":"PloS one"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/rheumatology\/kep230","article-title":"Psoriatic arthritis in Asia","volume":"48","author":"LS Tam","year":"2009","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"ref18","first-page":"101","article-title":"Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis","volume":"36","author":"Y-G Tsai","year":"2003","journal-title":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002960050109","article-title":"Spondylitis is the most common pattern of psoriatic arthritis in Korea","volume":"19","author":"HJ Baek","year":"2000","journal-title":"Rheumatology international"},{"issue":"9227","key":"ref20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"PJ Mease","year":"2000","journal-title":"The Lancet"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double\u2010blind, randomized, placebo\u2010controlled trial","volume":"52","author":"PJ Mease","year":"2005","journal-title":"Arthritis & Rheumatology"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.34436","article-title":"Golimumab in psoriatic arthritis: one\u2010year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo\u2010controlled trial","volume":"64","author":"A Kavanaugh","year":"2012","journal-title":"Arthritis & Rheumatology"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","article-title":"Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial","volume":"73","author":"C Ritchlin","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"key":"ref24","first-page":"2015","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)","author":"CJ Edwards","year":"2016","journal-title":"Annals of the rheumatic diseases"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/ard.2004.032268","article-title":"Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial","volume":"64","author":"C Antoni","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","article-title":"Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)","volume":"73","author":"PJ Mease","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"ref27","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"PJ Mease","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"ref28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"PJ Mease","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"PJ Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref30","article-title":"Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial","author":"P Nash","year":"2017","journal-title":"The Lancet"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis","volume":"377","author":"P Mease","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamadermatol.2018.0183","article-title":"Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in badbir","volume":"154","author":"KJ Mason","year":"2018","journal-title":"JAMA Dermatology"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1468-3083.2011.03985.x","article-title":"Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis","volume":"25","author":"Q Yang","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"s5","key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdv.12562","article-title":"Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review","volume":"28","author":"M Rouzaud","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","article-title":"The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics","volume":"24","author":"E Christophers","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","article-title":"Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis","volume":"76","author":"SM Thorarensen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-016-3460-1","article-title":"Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population","volume":"36","author":"YY Leung","year":"2017","journal-title":"Clinical rheumatology"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/bjd.13056","article-title":"Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12\/23 blocker, in Chinese patients with psoriasis: a retrospective analysis","volume":"171","author":"HY Chiu","year":"2014","journal-title":"The British journal of dermatology"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ced.13100","article-title":"HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment","volume":"42","author":"J West","year":"2017","journal-title":"Clinical and experimental dermatology"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI109903","article-title":"Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex","volume":"66","author":"C Murray","year":"1980","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0950-3579(94)80018-9","article-title":"Psoriatic arthritis. Genetics and HLA antigens","volume":"8","author":"CJ Eastmond","year":"1994","journal-title":"Bailliere's clinical rheumatology"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/rheumatology\/41.5.525","article-title":"Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis","volume":"41","author":"AM Al-Heresh","year":"2002","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"ref43","first-page":"ii37","article-title":"Genetic epidemiology of psoriasis and psoriatic arthritis","volume":"64","author":"P Rahman","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1744-313X.2005.00543.x","article-title":"HLA-C locus alleles distribution in patients from northern Poland with psoriatic arthritis\u2014preliminary report","volume":"32","author":"A Szczerkowska Dobosz","year":"2005","journal-title":"International journal of immunogenetics"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1399-0039.2010.01624.x","article-title":"HLA-C locus and genetic susceptibility to psoriatic arthritis in Romanian population","volume":"77","author":"OM Popa","year":"2011","journal-title":"Tissue antigens"},{"issue":"1","key":"ref46","first-page":"1","article-title":"Heterogeneity of Taiwan\u2019s indigenous population: possible relation to prehistoric Mongoloid dispersals","volume":"55","author":"M Lin","year":"2000","journal-title":"HLA"},{"issue":"Suppl 3","key":"ref47","doi-asserted-by":"crossref","first-page":"A965","DOI":"10.1136\/annrheumdis-2013-eular.2897","article-title":"AB0575 Prevalence of hla-cw * 06 and * 07 and its relationship with psoriatic arthritis in northwestern spain","volume":"72","author":"EA Blanco","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.humimm.2013.07.014","article-title":"Human leukocyte antigen alleles and susceptibility to psoriatic arthritis","volume":"74","author":"V Chandran","year":"2013","journal-title":"Hum Immunol"},{"issue":"5","key":"ref49","first-page":"891","article-title":"Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients","volume":"35","author":"H-T Liao","year":"2008","journal-title":"The Journal of rheumatology"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"e1000606","DOI":"10.1371\/journal.pgen.1000606","article-title":"Multiple Loci within the major histocompatibility complex confer risk of psoriasis","volume":"5","author":"B-J Feng","year":"2009","journal-title":"PLoS genetics"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.humimm.2013.07.014","article-title":"Human leukocyte antigen alleles and susceptibility to psoriatic arthritis","volume":"74","author":"V Chandran","year":"2013","journal-title":"Human immunology"},{"issue":"3","key":"ref52","first-page":"586","article-title":"HLA antigens in psoriatic arthritis","volume":"13","author":"DD Gladman","year":"1986","journal-title":"The Journal of rheumatology"},{"issue":"5","key":"ref53","first-page":"973","article-title":"MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis","volume":"29","author":"S Gonzalez","year":"2002","journal-title":"The Journal of rheumatology"},{"issue":"5","key":"ref54","first-page":"703","article-title":"Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes","volume":"9","author":"L Gerber","year":"1982","journal-title":"The Journal of rheumatology"},{"issue":"3","key":"ref55","first-page":"586","article-title":"HLA antigens in psoriatic arthritis","volume":"13","author":"D Gladman","year":"1986","journal-title":"The Journal of rheumatology"},{"issue":"4","key":"ref56","first-page":"391","article-title":"Clinical subgroups and HLA antigens in Italian patients with psoriatic arthritis","volume":"7","author":"C Salvarani","year":"1989","journal-title":"Clinical and experimental rheumatology"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10067-014-2739-3","article-title":"Clinical and immunogenetic characterization in psoriatic arthritis patients","volume":"34","author":"EE Schneeberger","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03009740410005953","article-title":"The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis","volume":"33","author":"R Queiro-Silva","year":"2004","journal-title":"Scandinavian journal of rheumatology"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/1523-1747.ep12476080","article-title":"Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701\/2, -DQA1*0201, -DQB1*0303 extended haplotype","volume":"100","author":"M Schmitt-Egenolf","year":"1993","journal-title":"The Journal of investigative dermatology"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2133.1998.02552.x","article-title":"HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population","volume":"139","author":"SH Jee","year":"1998","journal-title":"The British journal of dermatology"},{"issue":"1","key":"ref61","first-page":"96","article-title":"The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis","volume":"30","author":"E Korendowych","year":"2003","journal-title":"The Journal of rheumatology"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"L Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780380619","article-title":"The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model","volume":"38","author":"DD Gladman","year":"1995","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"ref64","first-page":"51","article-title":"Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min\u2010nan, Hakka, Aborigines and Mainland Chinese","volume":"53","author":"CK Shaw","year":"1999","journal-title":"HLA"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.humimm.2010.05.013","article-title":"Distributions of human leukocyte antigen\u2013A,\u2013B, and\u2013DRB1 alleles and haplotypes based on 46,915 Taiwanese donors","volume":"71","author":"M-J Lai","year":"2010","journal-title":"Human Immunology"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bjd.12331","article-title":"Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B\/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12\/23 blocker ustekinumab","volume":"169","author":"M Talamonti","year":"2013","journal-title":"The British journal of dermatology"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000441719","article-title":"IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis","volume":"232","author":"M Galluzzo","year":"2016","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaad.2015.08.055","article-title":"HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up","volume":"74","author":"M Talamonti","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjd.15387","article-title":"Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients","volume":"177","author":"M Talamonti","year":"2017","journal-title":"The British journal of dermatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:45:48Z","timestamp":1694562348000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210076"}},"subtitle":[],"editor":[{"given":"Wisit","family":"Cheungpasitporn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210076","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,1,16]]}}}